NFKB1 and cancer: While acute, high-grade inflammation has the potential to kill cancer cells, low-grade inflammation creates optimal conditions at all stages of cancer progression, including initiation, primary tumor growth and metastasis [277–279], and tumor-promoting activation of NF-κB in macrophages has been demonstrated [278, 280].